IGFBP7 and acute kidney injury: Nevertheless, the core conclusion is clear: urinary cell cycle arrest biomarkers (TIMP-2/IGFBP7) demonstrate consistent high diagnostic performance across all subgroups (different population characteristics, single/dual biomarker testing, and different testing technologies), confirming their universal diagnostic value for pediatric AKI.